SCHEMBL3822337

SCHEMBL3822337

COc1ccc(C2=C(c3ccccc3)C(=O)NC2=O)cc1

nearest known ligand 0.69

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 8/20 0.69
PTGS2 P35354 5/20 0.64
BACE1 P56817 1/20 0.54
GSK3A P49840 1/20 0.52
NR1H2 P55055 1/20 0.51
NR1H3 Q13133 1/20 0.51
PDE4B Q07343 1/20 0.50
ME2 P23368 1/20 0.50
ME1 P48163 1/20 0.50
ME3 Q16798 1/20 0.50
NPC1 O15118 1/20 0.50
TP53 P04637 1/20 0.50
MAPT P10636 1/20 0.50
TSHR P16473 1/20 0.50
RAB9A P51151 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28080907 0.92 PTGS2 (0.72) GSK3BPTGS2BACE1GSK3AME2
SCHEMBL12425030 0.86 GSK3B (0.57) GSK3BPTGS2BACE1GSK3ANR1H2
SCHEMBL4789169 0.84 GSK3B (0.62) GSK3BPTGS2GSK3A
SCHEMBL18049442 0.84 PTGS2 (0.62) GSK3BPTGS2GSK3AME2ME1
SCHEMBL4684025 0.82 GSK3B (0.89) GSK3BGSK3ANR1H2NR1H3
SCHEMBL7781089 0.82 GSK3B (1.00) GSK3BGSK3ANR1H2NR1H3MAPT
SCHEMBL114611 0.82 PTGS2 (0.67) GSK3BPTGS2PDE4B
SCHEMBL3677953 0.81 GSK3B (0.60) GSK3BPTGS2BACE1GSK3AME2
SCHEMBL13141855 0.81 BACE1 (0.62) GSK3BBACE1NR1H2NR1H3PDE4B
SCHEMBL9723700 0.81 BACE1 (0.62) GSK3BBACE1NR1H2NR1H3PDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4662319-A2 PERSONALIZED CRISPR PROFILING FOR CANCER Integrate Bioscience LLC (US) 2025-12-17 EP disclosed
WO-2024168301-A2 PERSONALIZED CRISPR PROFILING FOR CANCER FUNCTION ONCOLOGY, INC. (US) 2024-08-15 WO disclosed
EP-2091531-A2 PHENYL SUBSTITUTED MALEIMIDES AS MEDICAMENTS FOR BLOCKING DEGENERATIVE TISSUE DAMAGES BY INHIBITING MPT Congenia S.r.l. (IT) 2009-08-26 EP disclosed
WO-2008067863-A2 PHENYL SUBSTITUTED MALEIMIDES AS MEDICAMENTS FOR BLOCKING DEGENERATIVE TISSUE DAMAGES BY INHIBITING MPT CONGENIA S.R.L. (IT) 2008-06-12 WO disclosed